Predictive Oncology (NASDAQ: POAI), a data and
artificial-intelligence- (“AI”) driven, discovery-services company, today
announced that it has signed a letter of intent (“LOI”) to acquire Quantitative
Medicine (“QM”), a biomedical analytics and computational biology company. By
combining QM’s CoRE predictive modeling platform with POAI’s tumor profiling
proficiency and data, company management believes the acquisition will assist
in fast-tracking the commercialization of its AI-driven technology and
services. Subject to the negotiation of a definitive agreement and other terms
and conditions, the transaction is anticipated to be completed within the first
two quarters of 2020. “Our goal is to provide researchers in pharma, biopharma
and diagnostic companies’ with actionable insights that will not only drive the
development of new precision therapies, companion diagnostics, and biomarkers,
but will also help them design better targeted trials,” Predictive Oncology
president and CEO Dr. Carl Schwartz stated in the news release. “Working
together, we have the potential to dramatically improve patient outcomes.”
To view the full press release, visit http://ibn.fm/uIAbM
About Predictive Oncology
POAI is bringing precision medicine, or tailored medical
treatment using the individual characteristics of each patient, to the
treatment of cancer. Through its Helomics division, the company leverages its
unique, clinically validated patient-derived (PDx) smart tumor profiling
platform to provide oncologists with a roadmap to help individualize therapy.
In addition, the company is leveraging artificial intelligence and its
proprietary database of over 150,000 cancer cases to build AI-driven models of
tumor drug response to improve outcomes for the patients of today and tomorrow.
For more information, visit the company’s website at www.Predictive-Oncology.com.
NOTE TO INVESTORS: The latest news and updates
relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment